Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Glioma × fludarabine × Clear all

Phase

Status

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 33 Multiple Myeloma 26 Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma, Non-Hodgkin 22 Recurrence 21 Lymphoma 20 Neoplasms 16 Lymphoma, Large B-Cell, Diffuse 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Follicular 13 Lymphoma, B-Cell 13 Leukemia 13 Carcinoma, Non-Small-Cell Lung 13 Lymphoma, Mantle-Cell 12 Stomach Neoplasms 9 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Myelodysplastic Syndromes 6 Lymphoma, B-Cell, Marginal Zone 6 Carcinoma, Renal Cell 6 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Melanoma 5 Liposarcoma, Myxoid 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Myasthenia Gravis 4

Interventions

Temozolomide 28 Bevacizumab 10 Radiotherapy 9 Surgical Procedures, Operative 6 Lomustine 6 IL13-PE38 6 Carboplatin 6 TIC10 compound 5 vorasidenib 4 trametinib 4 dabrafenib 4 Flucytosine 4 Dianhydrogalactitol 4 Chlorotoxin 4 vocimagene amiretrorepvec 3 Radiation 3 Paclitaxel 3 OKN 007 3 Irinotecan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Cyclophosphamide 3 CLR1404 3 trans-sodium crocetinate 2 pembrolizumab 2 marizomib 2 lenvatinib 2 enzastaurin 2 contrast agent BR1 2 avapritinib 2 abemaciclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07480941 2026-03-18

DUAL-CAR-NK-GB

Beijing Biotech

Phase 1 Recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡